Vascular Endothelial Growth Factor and its receptors may be the pivotal stimulants in the process of growth and metastasis of a neoplasm. 血管內皮生長(cháng)因子及其受體在腫瘤的生長(cháng)和轉移過(guò)程中可能是最關(guān)鍵的刺激因子。
Beacizumab, a monoclonal antibody targeting ascular endothelial growth factor, is approed by the US Food and Drug Administration for metastatic colon cancer. 由美國食品與藥品管理局批準治療轉移克隆癌的貝伐單抗，是血管內皮生長(cháng)因子的單克隆抗體。
